IAM: Vogelstein R Jacob reports a stock award
By AlphaYouPublished Form 4
Vogelstein R Jacob
Reporting filer
Vogelstein R Jacob reports a stock award, not an open-market purchase or sale, in Iambic Therapeutics, Inc.. Form 4 filed Oct 16, 2026 lists 1 entry.
- Disclosed
- Oct 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | Vogelstein R Jacob | 2026-10-14 | A | Grant or award | 20300 | 0 | 20,300 | 2 days | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- Vogelstein R Jacob
- Date
- 2026-10-14
- Code
- A
- Action
- Grant or award
- Quantity
- 20300
- Price
- 0
- Following holdings
- 20,300
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 16
- transaction Date: 2026-10-14
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 20300
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-14
- underlying Security Title: Common Stock
- underlying Security Shares: 20300
- shares Owned Following Transaction: 20300
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Vogelstein R Jacob: Director, 10% owner.
- The filing reports a Rule 10b5-1 trading plan.
- F1: All of the shares subject to the option vest on October 14, 2027.
Original sources
Prepared automatically from public filing data. Report a correction.